» Articles » PMID: 33534418

Oral Nutritional Supplements, Physical Activity, and Sarcopenia in Cancer

Overview
Specialty General Medicine
Date 2021 Feb 3
PMID 33534418
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Sarcopenia is prevalent in cancer patients and can occur as a result of cancer as well as cancer-related therapies. It is related to high postoperative complications, long hospitalization, slow recovery as well as low tolerance to chemotherapy. Patients with sarcopenia also have poor oncological outcomes. Oral nutritional supplements (ONS) and physical activity have shown great potentials in managing this debilitating condition. We summarized the recent developments in the assessment of sarcopenia and its management with ONS and physical activity.

Recent Findings: Many methods were developed to evaluate sarcopenia including muscle quality/quantity measurement and functional tests. Recent studies have shown that ONS and physical training can be used in managing sarcopenia, especially when used together as part of a multimodal intervention. However, barriers such as low awareness and lack of training and support for both patients and healthcare workers still exist and need attention.

Summary: Recent findings highlighted the benefits of identifying sarcopenia and managing those at risk. The details of a multimodal protocol, such as components of nutritional substrates, the intensity of physical exercise, and the use of medication need to be further looked into for an optimum approach. Education and training programs need to be developed to overcome the barriers in managing sarcopenia.

Citing Articles

Muscle Loss During First-Line Chemotherapy Impairs Survival in Advanced Pancreatic Cancer Despite Adapted Physical Activity.

Parent P, Pigneur F, Hilmi M, Carnot A, Garcia Larnicol M, Vernerey D J Cachexia Sarcopenia Muscle. 2025; 16(1):e13595.

PMID: 39825571 PMC: 11788588. DOI: 10.1002/jcsm.13595.


Study of the significance of the combination of the fibrinogen-albumin ratio and sarcopenia in predicting the prognosis of laryngeal cancer patients undergoing radical surgery.

Zhang Y, Meng Z, Lu M, Ruan S, Zhou J, Zhang M BMC Cancer. 2024; 24(1):1265.

PMID: 39394062 PMC: 11468157. DOI: 10.1186/s12885-024-13039-2.


The effect of preoperative supplementary parenteral nutrition on nutrition and inflammation in gastric cancer patients.

Huang X, Cui C, Wang J, Kong D, Cui Y, Huang P Discov Oncol. 2024; 15(1):400.

PMID: 39225821 PMC: 11372033. DOI: 10.1007/s12672-024-01288-3.


Cancer history and physical function in patients with cardiovascular disease.

Miki T, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Yamashita M Heart Vessels. 2024; 39(7):654-663.

PMID: 38578318 DOI: 10.1007/s00380-024-02379-5.


Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine.

Takada E, Nakamura N, Kaneda Y, Fukuno K, Lee S, Fujita K Hematol Rep. 2024; 16(1):114-124.

PMID: 38534882 PMC: 10970390. DOI: 10.3390/hematolrep16010012.